Deferred Tax Assets, Operating Loss Carryforwards of HeartSciences Inc. from 30 Apr 2022 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
HeartSciences Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Apr 2022 to 31 Jul 2025.
  • HeartSciences Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Jul 2025 was $12,234,806, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

HeartSciences Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $12,234,806 +$576,565 +4.9% 31 Jul 2025 10-Q 11 Sep 2025 2025 Q1
Q1 2025 $11,774,383 +$395,974 +3.5% 30 Apr 2025 10-Q 11 Sep 2025 2025 Q1
Q4 2024 $10,898,410 -$67,419 -0.62% 31 Jan 2025 10-Q 13 Mar 2025 2025 Q3
Q3 2024 $10,413,290 -$147,910 -1.4% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q2
Q2 2024 $11,658,241 +$1,389,695 +14% 31 Jul 2024 10-Q 12 Sep 2024 2025 Q1
Q1 2024 $11,378,409 +$1,676,759 +17% 30 Apr 2024 10-K 24 Jul 2025 2025 FY
Q4 2023 $10,965,829 +$1,518,617 +16% 31 Jan 2024 10-Q 14 Mar 2024 2024 Q3
Q3 2023 $10,561,200 +$1,503,067 +17% 31 Oct 2023 10-Q 14 Dec 2023 2024 Q2
Q2 2023 $10,268,546 +$1,589,320 +18% 31 Jul 2023 10-Q 14 Sep 2023 2024 Q1
Q1 2023 $9,701,650 +$1,313,769 +16% 30 Apr 2023 10-K 29 Jul 2024 2024 FY
Q4 2022 $9,447,212 31 Jan 2023 10-Q 16 Mar 2023 2023 Q3
Q3 2022 $9,058,133 31 Oct 2022 10-Q 15 Dec 2022 2023 Q2
Q2 2022 $8,679,226 31 Jul 2022 10-Q 12 Sep 2022 2023 Q1
Q1 2022 $8,387,881 30 Apr 2022 10-K 19 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.